Integracides: Tetracyclic triterpenoid inhibitors of HIV-1 integrase produced by Fusarium sp.

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 7, 2003, Pages 1577-1582

  Singh, Sheo B ^a   Zink, Deborah L ^a   Dombrowski, Anne W ^a   Polishook, Jon D ^a   Ondeyka, John G ^a   Hirshfield, Jorden ^a   Felock, Peter ^a   Hazuda, Daria J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTER; INTEGRASE; TRITERPENOID;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; FERMENTATION; FUSARIUM; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; SULFATION; VIRUS REPLICATION; X RAY;

CRYSTALLOGRAPHY, X-RAY; FERMENTATION; FUSARIUM; HIV INTEGRASE; HIV INTEGRASE INHIBITORS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TRITERPENES;

FUSARIUM; FUSARIUM SP.; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0037375431     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(02)00529-1     Document Type: Article

References (23)

1. For recent reviews on HIV integrase, see: (a) Craigie R. J. Biol. Chem. 276:2001;23213 (b) Esposito D., Craigie R. Adv. Virus Res. 52:1999;319.
2. For recent reviews on HIV integrase, see: (a) Craigie R. J. Biol. Chem. 276:2001;23213 (b) Esposito D., Craigie R. Adv. Virus Res. 52:1999;319.
3. (a) Hazuda D.J., Felock P., Witmer M., Wolfe A., Stillmock K., Grobler J.A., Espeseth A., Gabryelski L., Schleif W., Blau C., Miller M.D. Science. 287:2000;646.
4. (b) Wai J.S., Egbertson M.S., Payne L.S., Fisher T.E., Embrey M.W., Tran L.O., Melamed J.Y., Langford H.M., Guare J.P., Zhuang L., Grey V.E., Vacca J.P., Holloway M.K., Naylor-Olsen A.M., Hazuda D.J., Felock P.J., Wolfe A.L., Stillmock K.A., Schleif W., Gabryelski L.J., Young S.D. J. Med. Chem. 43:2000;4923
5. (c) Neamati N. Exp. Opin. Invest. Drugs. 10:2001;281.
6. (a) Singh S.B., Zink D.L., Goetz M.A., Dombrowski A.W., Polishook J.D., Hazuda D.L. Tetrahedron Lett. 39:1998;2243.
7. (b) Hazuda D., Blau C.U.C., Felock P., Hastings J., Pramanik B., Wolfe A., Bushman F., Farnet C., Goetz M., Williams M., Silverman K., Lingham R., Singh S. Antiviral Chem. Chemother. 10:1999;63.
8. (a) Singh S.B., Zink D., Polishook J., Valentino D., Shafiee A., Silverman K., Felock P., Teran A., Vilella D., Hazuda D.J., Lingham R.B. Tetrahedron Lett. 40:1999;8775.
9. (b) Singh S.B., Felock P., Hazuda D.J. Bioorg. Med. Chem. Lett. 10:2000;235.
10. Singh S.B., Jayasuriya H., Salituro G.M., Zink D.L., Shafiee A., Heimbuch B., Silverman K.C., Lingham R.B., Genilloud O., Teran A., Vilella D., Felock P., Hazuda D. J. Nat. Prod. 64:2001;874.
11. Singh S.B., Zink D., Bills G.F., Pelaez F., Teran A., Collado J., Silverman K., Lingham R.B., Felock P., Hazuda D.J. Tetrahedron Lett. 43:2002;1617.
12. Singh S.B., Zink D.L., Quamina D.S., Pelaez F., Teran A., Felock P., Hazuda D.J. Tetrahedron Lett. 43:2002;2351.
13. Singh S.B., Zink D.L., Heimbach B., Genilloud O., Teran A., Silverman K.C., Lingham R.B., Felock P., Hazuda D.J. Organic Lett. 4:2002;1123.
14. For details of vermiculite media, see for example, (a) Singh S.B., Zink D.L., Liesch J.M., Moseley R.T., Dombrowski A.W., Bills G.F., Darkin-Rattray S.J., Schmatz D.M., Goetz M.A. J. Org. Chem. 67:2002;815 (b) Dombrowski A., Bills G.F., Sabnis G., Koupal L.R., Meyer R., Ondeyka J.G., Giacobbe R.A., Monaghan R.L., Lingham R.B. J. Antibiot. 45:1992;671.
15. For details of vermiculite media, see for example, (a) Singh S.B., Zink D.L., Liesch J.M., Moseley R.T., Dombrowski A.W., Bills G.F., Darkin-Rattray S.J., Schmatz D.M., Goetz M.A. J. Org. Chem. 67:2002;815 (b) Dombrowski A., Bills G.F., Sabnis G., Koupal L.R., Meyer R., Ondeyka J.G., Giacobbe R.A., Monaghan R.L., Lingham R.B. J. Antibiot. 45:1992;671.
16. For details of AD2 media, see for example, Dombrowski A., Jenkins R., Raghoobar S., Bills G., Polishook J., Pelaez F., Burgess B., Zhao A., Huang L., Zhang Y., Goetz M. J. Antibiot. 52:1999;1077.
17. Singh S.B. Tetrahedron Lett. 41:2000;6973.
18. (a) Burg, R. W.; Dulaney, E. L.; Hensens, O. D.; Liesch, J. M.; Ondeyka, J. G.; Wichman, C. F. (Merck & Co., Inc.) US 4871727, Oct. 3, 1989.
19. (b) Ashe, B. M.; Fletcher, S. (Merck & Co., Inc.) US 4874755, Oct. 17, 1989.
20. (c) CCDC 184245 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html (or from the CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44-1223-336033; e-mail: deposit@ccdc.cam.ac.uk.
21. Brill G.M., Kati W.M., Montgomery D., Karwowski J.P., Humphrey P.E., Jackson M., Clement J.J., Kadam S., Chen R.H., McAlpine J.B. J. Antibiot. 49:1990;541.
22. (a) Reddy M.V.R., Rao M.R., Rhodes D., Hansen M.S.T., Rubins K., Bushman F.D., Venkateswarlu Y., Faulkner D.J. J. Med. Chem. 42:1999;1901
23. (b) Mitchell S.S., Rhodes D., Bushman F.D., Faulkner D.J. Organic Lett. 2:2000;1605.